Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
Abstract
Altered intestinal O-glycan expression has been observed in patients with ulcerative colitis and colorectal cancer, but the role of this alteration in the etiology of these diseases is unknown. O-glycans in mucin core proteins are the predominant components of the intestinal mucus, which comprises part of the intestinal mucosal barrier. Core 3–derived O-glycans, which are one of the major types of O-glycans, are primarily expressed in the colon. To investigate the biological function of core 3–derived O-glycans, we engineered mice lacking core 3 β1,3-N-acetylglucosaminyltransferase (C3GnT), an enzyme predicted to be important in the synthesis of core 3–derived O-glycans. Disruption of the C3GnT gene eliminated core 3–derived O-glycans. C3GnT-deficient mice displayed a discrete, colon-specific reduction in Muc2 protein and increased permeability of the intestinal barrier. Moreover, these mice were highly susceptible to experimental triggers of colitis and colorectal adenocarcinoma. These data reveal a requirement for core 3–derived O-glycans in resistance to colonic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The importance of sufficiently complex mucin glycans was demonstrated in studies of mice with truncated glycans as found in O-glycan core 1 or core 3 deficient mice 19, 28.”
From The composition of the gut microbiota shapes the colon mucus barrier (2015) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Self-citationNadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,938
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542 · cited 1×
“This distinguishes C3GnT−/− mice from models of TH1 or TH17 colitis (42, 49, 50).”
BackgroundLinking Colorectal Cancer to Wnt Signaling
Bienz, M., & Clevers, H. (2000) · Cell · doi:10.1016/s0092-8674(00)00122-7 · Cited by 1,515 · cited 2×
“The altered expression of β-catenin/TCF-4, c-myc, and cyclin D1 observed during carcinogenesis in C3GnT−/− mice relates its molecular pathogenesis to that commonly observed in human colorectal cancer (35).”
BackgroundThe Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304 · cited 3×
“The relatively modest immune infl ammatory components in Muc2−/− and C3GnT−/− mice suggest that defi ciencies in mucus layer integrity alone are insuffi cient to drive immune colitis, without the contribution of additional traits aff ecting innate immune function or immunoregulation (42).”
BackgroundImmunity, Inflammation, and Allergy in the Gut
MacDonald, T. T., & Monteleone, G. (2005) · Science · doi:10.1126/science.1106442 · Cited by 1,035 · cited 1×
“Products of these and other immune cell types can induce abnormal epithelial cell growth and survival that contribute to carcinogenesis (9, 52).”
BackgroundColorectal Cancer in Mice Genetically Deficient in the Mucin Muc2
Velcich, A., Yang, W., Heyer, J., Fragale, A., Nicholas, C., Viani, S., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. (2002) · Science · doi:10.1126/science.1069094 · Cited by 936 · cited 8×
“In another experiment, PAS (Sigma-Aldrich) and Alcian blue (Newcomer Supply) were used to stain general intestinal carbohydrate moieties.”
BackgroundMethodInfluentialFuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797 · cited 1×
“This distinguishes C3GnT−/− mice from models of TH1 or TH17 colitis (42, 49, 50).”
Background
Cited by
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Disruption of this layer by genetically altering mucin backbones, O-linked glycosyltransferases (or key chaperones like Cosmc) can have very serious consequences, including inflammation and carcinogenesis associated with microbial invasion (453) (454) (455) (456) .”
BackgroundThe inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
“Sampleswereanalyzed by PCR with universal primers directed against a region of the 16S rRNA gene common to most bacteria: set1 (forward 5 -CCATGAAGTCGGAATCGCTAG-3 and reverse, 5 -ACTCCCATGGTGTGACGG-3 ) (bp 1302–1394 in bacteria EU622773) and set2 (forward, 5 -TCCTACGGGAGGCAGCAGT-3 ; reverse, 5 -GGACTACCAGGGTATCTAATCCT…”
InfluentialGlycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress
Kim, Y. S., & Ho, S. B. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0131-2 · Cited by 1,435
Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M. H., Schütte, A., van der Post, S., Svensson, F., Rodríguez‐Piñeiro, A. M., Nyström, E. E. L., et al. (2014) · Immunological Reviews · doi:10.1111/imr.12182 · Cited by 1,363
“If the glycans are shorter, the degradation process will be faster and not only the outer mucus layer but also the inner can be degraded fast enough to allow bacteria to reach the epithelium (47, 48).”
The composition of the gut microbiota throughout life, with an emphasis on early life
Rodríguez, J. M., Murphy, K., Stanton, C., Ross, R. P., Kober, O. I., Juge, N., Avershina, E., Rudi, K., Narbad, A., Jenmalm, M. C., et al. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26050 · Cited by 1,318
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,023
“In addition, a more recent study clearly demonstrated a critical role of intestinal mucus layer for the suppression of colitis (44).”
Martens, E. C., Chiang, H. C., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.007 · Cited by 937
“…is able to rebound from physiologic or pharmacologic perturbations, and the forces that regulate interactions between the microbiota and components of innate and adaptive immune systems in health and disease (An et al., 2007; Heazlewood et al., 2008; Peterson et al., 2008; Swidsinski et al., 2007).”
Mucin glycan foraging in the human gut microbiome
Tailford, L. E., Crost, E. H., Kavanaugh, D., & Juge, N. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00081 · Cited by 839
“…with a number of diseases such as colitis, colonic cancer and inflammatory bowel diseases in humans (e.g., McGovern et al., 2010; Larsson et al., 2011; Rausch et al., 2011; Parmar et al., 2012; Forni et al., 2014) and mouse models (e.g., An et al., 2007; Stone et al., 2009; Fu et al., 2011).”
BackgroundProtein-glycan interactions in the control of innate and adaptive immune responses
van Kooyk, Y., & Rabinovich, G. A. (2008) · Nature Immunology · doi:10.1038/ni.f.203 · Cited by 807
“It has been recently found that deficiency of the core 3 transferase C3GnT results in elimination of core 3–derived O-glycans and presentation of naked Tn antigen in mouse colonic epitheliu”
BackgroundExperimental Models of Inflammatory Bowel Diseases
Kiesler, P., Fuss, I. J., & Strober, W. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.01.006 · Cited by 713
Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier
Martens, E. C., Neumann, M., & Desai, M. S. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0036-x · Cited by 711
Heazlewood, C. K., Cook, M. C., Eri, R., Price, G. R., Tauro, S. B., Taupin, D., Thornton, D. J., Png, C. W., Crockford, T. L., Cornall, R. J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050054 · Cited by 701
“Furthermore, a reduction in a specific biochemical fraction of colonic mucin has been described in UC patients and in their unaffected monozygotic twins [18,19], and engineered changes in intestinal mucin glycosylation result in enhanced susceptibility to toxininduced colitis [20], raising the possibility that genetic…”
BackgroundThe composition of the gut microbiota shapes the colon mucus barrier
Jakobsson, H. E., Rodríguez‐Piñeiro, A. M., Schütte, A., Ermund, A., Boysen, P., Bemark, M., Sommer, F., Bäckhed, F., Hansson, G. C., & Johansson, M. E. (2015) · The EMBO Reports · doi:10.15252/embr.201439263 · Cited by 700
“The importance of sufficiently complex mucin glycans was demonstrated in studies of mice with truncated glycans as found in O-glycan core 1 or core 3 deficient mice [19,28].”
Intestinal barrier dysfunction in inflammatory bowel diseases
McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J., & Radford-Smith, G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20539 · Cited by 627
Multifarious roles of sialic acids in immunity
Varki, A., & Gagneux, P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06517.x · Cited by 611
Mucin-bacterial interactions in the human oral cavity and digestive tract
Derrien, M., van Passel, M. W. J., van de Bovenkamp, J. H. B., Schipper, R., de Vos, W., & Dekker, J. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12778 · Cited by 556
Cockburn, D. W., & Koropatkin, N. M. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.06.021 · Cited by 539
Roles and regulation of the mucus barrier in the gut
Cornick, S., Tawiah, A., & Chadee, K. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.982426 · Cited by 526
“These mice are unable to synthesize core-3 glycans and as a result, Muc2 expression is significantly reduced and the barrier rendered highly susceptible to experimental colitis and adenocarinoma.(101) This mouse model has also been used in the context of enterocolitis induced by Salmonella, where transgenic animals ha…”
ResultThe intestinal barrier: a pivotal role in health, inflammation, and cancer
Neurath, M. F., Artis, D., & Becker, C. (2025) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00390-x · Cited by 487
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases
Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503
Grondin, J. A., Kwon, Y. H., Far, P. M., Haq, S., & Khan, W. I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02054 · Cited by 465
“Further, inhibition of the enzyme, core 3 β1,3-N-acetylglucosaminyltransferase (C3GnT) which plays a crucial role in the addition of Olinked oligosaccharides, can alter the structural and functional features of mucins and has been shown to decrease MUC2 levels and increase intestinal permeability (184, 209).”
BackgroundFucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease
McGovern, D. P. B., Jones, M. R., Taylor, K. D., Marciante, K., Yan, X., Dubinsky, M., Ippoliti, A., Vasiliauskas, E., Berel, D., Derkowski, C., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq248 · Cited by 379
Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis Model
Johansson, M. E. V., Gustafsson, J. K., Sjöberg, K. E., Petersson, J., Holm, L., Sjövall, H., & Hansson, G. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012238 · Cited by 368
“In mice with a thinner or no functional mucus layer, as for example germ-free mice, DSS treatment induces an acute and massive bleeding long before any inflammation is observed [20,25,26].”
BackgroundLoss of intestinal core 1–derived O-glycans causes spontaneous colitis in mice
Fu, J., Wei, B., Wen, T., Johansson, M. E. V., Liu, X., Bradford, E., Thomsson, K. A., McGee, S., Mansour, L., Tong, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45538 · Cited by 366
“Intestinal intraepithelial lymphocytes from colons were isolated as described(3).”
BackgroundSelf-citationThe Tn Antigen—Structural Simplicity and Biological Complexity
Ju, T., Otto, V. I., & Cummings, R. D. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201002313 · Cited by 363
Self-citationMucin-type O-glycans and their roles in intestinal homeostasis
Bergstrom, K. S. B., & Xia, L. (2013) · Glycobiology · doi:10.1093/glycob/cwt045 · Cited by 360
Self-citationIntestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Kudelka, M. R., Stowell, S. R., Cummings, R. D., & Neish, A. S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0331-7 · Cited by 355
Self-citationFunctions of ocular surface mucins in health and disease
Mantelli, F., & Argüeso, P. (2008) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32830e6b04 · Cited by 343
Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
Rabinovich, G. A., & Croci, D. O. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.004 · Cited by 338
Microbial adhesins to gastrointestinal mucus
Juge, N. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2011.10.001 · Cited by 303
Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
Ju, T., Lanneau, G. S., Gautam, T., Wang, Y., Xia, B., Stowell, S. R., Willard, M. T., Wang, W., Xia, J. Y., Zuna, R. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2345 · Cited by 292
“Genetic ablation of the core 3 h1,3-N-acetylglucosaminyltransferase (C3GnT) leads to loss of core 3 structures and increased susceptibility to colitis and colorectal tumor formation, which is also correlated with a deficiency of colon surface expressed MUC2 (50).”
BackgroundSelf-citationLiu, X., Zhang, Y., Li, W., Zhang, B., Yin, J., Liuqi, S., Wang, J., Peng, B., & Wang, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06417 · Cited by 284
Mucin-type O-Glycosylation during Development
Tran, D. T., & Ten Hagen, K. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.418558 · Cited by 269
“Additionally, loss of the 1,3-N-acetylglucosaminyltransferase 6 gene (responsible for formation of the core 3 structure) caused decreased mucosal integrity and increased susceptibility to induced colitis and colon cancer (65).”
BackgroundAnimal Models of Inflammatory Bowel Disease
(2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-394596-9.00009-3 · Cited by 267
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W., Bennett, E. P., Mandel, U., Ragupathi, G., Livingston, P. O., Hollingsworth, M. A., Taylor-Papadimitriou, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2893 · Cited by 266
“Interestingly, overexpression of β3GnT6 in cancer cells suppresses the metastatic phenotype, and mice deficient in this enzyme spontaneously develop colon cancer (47).”
Targeting Glycosylation: A New Road for Cancer Drug Discovery
Costa, A. F., Campos, D., Reis, C. A., & Gomes, C. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.04.002 · Cited by 263
Simple Sugars to Complex Disease—Mucin-Type O-Glycans in Cancer
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2014.11.002 · Cited by 260
Self-citationMethods to determine intestinal permeability and bacterial translocation during liver disease
Wang, L., Llorente, C., Hartmann, P., Yang, A.-M., Chen, P., & Schnabl, B. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.12.015 · Cited by 257
“Intestinal permeability will be presented as the concentration of serum FITC-dextran (Napolitano et al., 1996; Furuta et al., 2001; An et al., 2007; Fouts et al., 2012; Hartmann et al., 2013).”
BackgroundArgüeso, P., Guzman-Aranguez, A., Mantelli, F., Cao, Z., Ricciuto, J., & Panjwani, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033332 · Cited by 257
Proximal colon–derived O-glycosylated mucus encapsulates and modulates the microbiota
Bergstrom, K., Shan, X., Casero, D., Batushansky, A., Lagishetty, V., Jacobs, J. P., Hoover, C., Kondo, Y., Shao, B., Gao, L., et al. (2020) · Science · doi:10.1126/science.aay7367 · Cited by 245
Self-citationCancer vaccines and carbohydrate epitopes
Heimburg-Molinaro, J., Lum, M., Vijay, G., Jain, M., Almogren, A., & Rittenhouse-Olson, K. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.009 · Cited by 227
“Decreased core 3 enzyme levels have been correlated with colon cancer [50–52], while overexpression of ST6GalNAc-I competes with T-synthase to cause expression of STn, which correlates with colon and breast tumors [53,54].”
BackgroundArike, L., & Hansson, G. C. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.02.010 · Cited by 224
“The importance of sufficiently long O-glycans is illustrated by the Core3 -/mice that are more susceptible to dextran sulfate colitis (DSS) and the Core1 -/mice that can spontaneously develop colitis [59,60].”
Herath, M., Hosie, S., Bornstein, J. C., Franks, A. E., & Hill-Yardin, E. L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00248 · Cited by 213
“Furthermore, multiple studies report that alterations in mucus secretory processes result in an underdeveloped colonic inner mucus layer, often associated with sparsely filled goblet cells and an increased susceptibility to colitis (An et al., 2007; Park et al., 2009; Stone et al., 2009; Fu et al., 2011; Tsuru et al.,…”
BackgroundHolmén Larsson, J. M., Thomsson, K. A., Rodríguez-Piñeiro, A. M., Karlsson, H., & Hansson, G. C. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2013 · Cited by 208
Zarepour, M., Bhullar, K., Montero, M., Ma, C., Huang, T., Velcich, A., Xia, L., & Vallance, B. A. (2013) · Infection and Immunity · doi:10.1128/iai.00854-13 · Cited by 206
“In agreement with previous findings (13), we found that core 3 O-glycosylation plays a major role in protecting intestinal barrier function.”
BackgroundSelf-citationBroadhurst, M. J., Leung, J. M., Kashyap, V., McCune, J. M., Mahadevan, U., McKerrow, J. H., & Loke, P. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001500 · Cited by 198
Mucins in inflammatory bowel diseases and colorectal cancer
Sheng, Y. H., Hasnain, S. Z., Florin, T. H. J., & McGuckin, M. A. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06909.x · Cited by 193
Recent insights into the biological roles of mucin-type O-glycosylation
Tian, E., & Ten Hagen, K. G. (2009) · Glycoconjugate Journal · doi:10.1007/s10719-008-9162-4 · Cited by 191
“highly susceptible to induced colitis and colorectal tumors [76].”
BackgroundBergstrom, K., Fu, J., Johansson, M. E. V., Liu, X., Gao, N., Wu, Q., Song, J., McDaniel, J. M., McGee, S., Chen, W., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.45 · Cited by 188
“16,17 Our previous studies show that mice lacking C3GnT (C3GnT −/− ) are more susceptible to chemically-induced colitis, 13 and intestinal epithelial-specific deletion of C1GalT1 (IEC C1galt1 −/− ) leads to spontaneous colitis.”
Self-citationSymbiotic Human Gut Bacteria with Variable Metabolic Priorities for Host Mucosal Glycans
Pudlo, N. A., Urs, K., Kumar, S. S., German, J. B., Mills, D. A., & Martens, E. C. (2015) · mBio · doi:10.1128/mbio.01282-15 · Cited by 187
A refined palate: Bacterial consumption of host glycans in the gut
Marcobal, A., Southwick, A. M., Earle, K. A., & Sonnenburg, J. L. (2013) · Glycobiology · doi:10.1093/glycob/cwt040 · Cited by 178
Experimental models to study intestinal microbes–mucus interactions in health and disease
Etienne-Mesmin, L., Chassaing, B., Desvaux, M., De Paepe, K., Gresse, R., Sauvaitre, T., Forano, E., de Wiele, T. V., Schüller, S., Juge, N., et al. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz013 · Cited by 178
Global functions of O‐glycosylation: promises and challenges in O‐glycobiology
Wandall, H. H., Nielsen, M. A. I., King‐Smith, S., de Haan, N., & Bagdonaite, I. (2021) · The FEBS Journal · doi:10.1111/febs.16148 · Cited by 166
Tn and sialyl‐Tn antigens, aberrant O‐glycomics as human disease markers
Ju, T., Wang, Y., Aryal, R. P., Lehoux, S. D., Ding, X., Kudelka, M. R., Cutler, C., Zeng, J., Wang, J., Sun, X., et al. (2013) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300024 · Cited by 164
“However, while knockout of C3GnT in mice only results in low expression of Tn antigen [17], IEC T-synthase knockout mice develop colitis and have massive Tn antigen expression in the IECs [18], indicating that C3GnT cannot compensate for T-synthase in these cells.”
BackgroundSelf-citationDefective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice
Bergstrom, K., Liu, X., Zhao, Y., Gao, N., Wu, Q., Song, K., Cui, Y., Li, Y., McDaniel, J. M., McGee, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.039 · Cited by 162
Self-citationThe role of glycosylation in IBD
Theodoratou, E., Campbell, H., Ventham, N. T., Kolarich, D., Pučić-Baković, M., Zoldoš, V., Fernandes, D., Pemberton, I. K., Rudan, I., Kennedy, N. A., et al. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.78 · Cited by 162
Andoh, A., Shioya, M., Nishida, A., Bamba, S., Tsujikawa, T., Kim‐Mitsuyama, S., & Fujiyama, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804169 · Cited by 169
The Cosmc connection to the Tn antigen in cancer
Ju, T., Aryal, R. P., Kudelka, M. R., Wang, Y., & Cummings, R. D. (2014) · Cancer Biomarkers · doi:10.3233/cbm-130375 · Cited by 153
“tion of core 3 β3-GlcNAcT in mice leads to a low level expression of the Tn antigen in the GI tract epithelial cells [54].”
Self-citationIndole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22–dependent manner
Busbee, P. B., Menzel, L., Alrafas, H., Dopkins, N., Becker, W., Miranda, K., Tang, C., Chatterjee, S., Singh, U., Nagarkatti, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.127551 · Cited by 152
“gut permeability, the FITC-dextran assay was used as reported elsewhere (89).”
MethodMechanisms of cancer-associated glycosylation changes
Dall'Olio, F. (2012) · Frontiers in Bioscience · doi:10.2741/3951 · Cited by 152
“While the presence of core-3 based glycans prevented colitis and colorectal cancer in a murine model (145), the expression of Tn, sTn and T antigens has often been correlated with cancer progression (146).”
BackgroundThe Role and Function of Mucins and Its Relationship to Inflammatory Bowel Disease
Kang, Y., Park, H., Choe, B., & Kang, B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.848344 · Cited by 199
Mucin Function in Inflammatory Bowel Disease: An Update
Boltin, D., Perets, T. T., Vilkin, A., & Niv, Y. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182688e73 · Cited by 154
Sommer, F., Adam, N., Johansson, M. E. V., Xia, L., Hansson, G. C., & Bäckhed, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085254 · Cited by 150
“Finally, loss of core 3-derived O-glycans results in greater susceptibility to DSS-induced colitis [16] and loss of core 1derived O-glycans has been reported to lead to spontaneous colitis [17].”
BackgroundSelf-citationMucus Layers in Inflammatory Bowel Disease
Johansson, M. E. V. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000117 · Cited by 148
“Increased mucus degradation was observed in mice with shorter glycan structures due lack of glycosyltransferases that normally extend the mucin glycans into core 1 or core 3 structures.(44,57,58) The shorter glycans in these mice were digested faster, something that will expose the protein core, and”
BackgroundInflammatory bowel disease, past, present and future: lessons from animal models
Mizoguchi, A., & Mizoguchi, E. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-007-2111-3 · Cited by 168
Structure and Biological Roles of Mucin-type O-glycans at the Ocular Surface
Guzmán‐Aránguez, A., & Argüeso, P. (2010) · The Ocular Surface · doi:10.1016/s1542-0124(12)70213-6 · Cited by 145
Crouch, L. I., Liberato, M. V., Urbanowicz, P. A., Baslé, A., Lamb, C. A., Stewart, C. J., Cooke, K., Doona, M., Needham, S., Brady, R. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17847-5 · Cited by 145
Verhelst, X., Dias, A. M., Colombel, J., Vermeire, S., Vlierberghe, H. V., Callewaert, N., & Pinho, S. S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.060 · Cited by 159
Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa
Dupont, A., Heinbockel, L., Brandenburg, K., & Hornef, M. W. (2014) · Gut Microbes · doi:10.4161/19490976.2014.972238 · Cited by 140
“Similarly, mice deficient in muc13 or core 3 ß1,3N-acetylglucosaminyl-transferase (C3GnT) with therefore a reduced mucin O-glycosylation exhibit an enhanced susceptibility to inflammation.(46,47) Also, aberrant mucin assembly-associated ER stress in goblet and Paneth cells was reported in 2 strains of muc2 mutant mice…”
BackgroundKang, M., & Martín, A. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.04.003 · Cited by 152
Regulation of the Intestinal Barrier Function by Host Defense Peptides
Robinson, K., Deng, Z., Hou, Y., & Zhang, G. (2015) · Frontiers in Veterinary Science · doi:10.3389/fvets.2015.00057 · Cited by 162
“Moreover, mice lacking the enzyme, β1,3-N-acetylglucosaminyltransferase that synthesizes O-glycans on mucins, exhibit a thinner mucus layer showing an enhanced susceptibility to enteric bacterial infections (67) and dextran sodium sulfate (DSS)-induced colitis (68).”
BackgroundTargeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Berois, N., Pittini, Á., & Osinaga, E. (2022) · Cancers · doi:10.3390/cancers14030645 · Cited by 154
Ju, T., Aryal, R. P., Stowell, C. J., & Cummings, R. D. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711151 · Cited by 134
“The online version of this paper contains supplemental material.”
Self-citationThe Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human
Corfield, A. P. (2018) · Microorganisms · doi:10.3390/microorganisms6030078 · Cited by 133
“This may be due to the loss of the core 1 and core3 synthases [467] [468] [469] [470] [471] or depletion of the β1-3-N-acetylglucosaminyl-transferase.”
BackgroundDawson, P. A., Huxley, S., Gardiner, B., Tran, T., McAuley, J. L., Grimmond, S., McGuckin, M. A., & Markovich, D. (2009) · Gut · doi:10.1136/gut.2007.147595 · Cited by 131
Healing of intestinal inflammation by IL-22
Mizoguchi, A. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22929 · Cited by 152
“Indeed, impaired glycosylation in the mucus exacerbates or causes colitis.(65,66) Interestingly, the ability of IL22 to promote the production of functional Muc1 through activation of STAT3, but not STAT1, has been demon-”
BackgroundTsuboi, K., Nishitani, M., Takakura, A., Imai, Y., Komatsu, M., & Kawashima, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.632257 · Cited by 125
Display of the human mucinome with defined O-glycans by gene engineered cells
Nason, R., Büll, C., Konstantinidi, A., Sun, L., Ye, Z., Halim, A., Du, W., Sørensen, D. M., Durbesson, F., Furukawa, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24366-4 · Cited by 122
Tobisawa, Y., Imai, Y., Fukuda, M., & Kawashima, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.067082 · Cited by 120
Glycosyltransferase Function in Core 2-Type Protein O Glycosylation
Stone, E. L., Ismail, M. N., Lee, S. H., Luu, Y., Ramirez, K., Haslam, S. M., Ho, S. B., Dell, A., Fukuda, M., & Marth, J. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00204-09 · Cited by 117
“Moreover, the single C3GnT glycosyltransferase that generates core 3 O-glycans is also essential for mucosal barrier function and similarly decreases susceptibility to DSSinduced colitis (2).”
BackgroundBacterial-mucosal interactions in inflammatory bowel disease—an alliance gone bad
Chichlowski, M., & Hale, L. P. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90516.2008 · Cited by 115
“C3GnT-deficient mice exhibit impaired colonic mucus layer formation, colon-specific reduction in Muc2, and increased intestinal permeability (2).”
BackgroundInfluentialWestbrook, A. M., Szakmary, A., & Schiestl, R. H. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.03.001 · Cited by 133
“An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, Braun J, Xia L. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.”
BackgroundIntestinal Mucosal Inflammation Leads to Systemic Genotoxicity in Mice
Westbrook, A. M., Wei, B., Braun, J., & Schiestl, R. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4416 · Cited by 110
“Penetrance correlates to duration of inflammation produced either by recurrent administration alone (17, 18) or by brief exposure in mice with genetic traits that amplify and perpetuate colitis (6, 7, 11).”
BackgroundSelf-citationCornick, S., Kumar, M., Moreau, F., Gaisano, H. Y., & Chadee, K. (2019) · Nature Communications · doi:10.1038/s41467-019-11811-8 · Cited by 120
Tenno, M., Ohtsubo, K., Hagen, F. K., Ditto, D., Zarbock, A., Schaerli, P., von Andrian, U. H., Ley, K., Le, D., Tabak, L. A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01204-07 · Cited by 109
“Furthermore, it was recently shown that a loss of core 3 O-glycans in mice increases their susceptibility to colitis and colorectal tumors (1).”
BackgroundThomsson, K. A., Holmén-Larsson, J. M., Ångström, J., Johansson, M. E., Xia, L., & Hansson, G. C. (2012) · Glycobiology · doi:10.1093/glycob/cws083 · Cited by 101
“The core 2 β1,6 N-acetylglucosaminyltransferase 2 (C2Gnt2) and the core 3 (C3Gnt) knockout mice both displayed increased susceptibility to colitis in the DSS colitis model (An et al. 2007; Stone et al. 2009).”
BackgroundSelf-citationOkumura, R., & Takeda, K. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01026-5 · Cited by 121
“In contrast, B3gnt6-deficient mice, which lack the core 3 O -glycan, did not develop spontaneous colitis but displayed heightened susceptibility to dextran sulfate sodium (DSS)- induced experimental colitis because of a weakened mucus barrier [31].”
Harvey, D. J. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20265 · Cited by 105
Bergstrom, K., & Xia, L. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2052699 · Cited by 113
“The Tn structure, which normally is not an exposed structure in most tissues, is further modified by at least two major glycosyltransferases: core 1 β1,3 galactosyltransferase (C1GalT1) and core 3 β1,3 N-acetylglucosaminyltransferase C3GnT (also called β3GnT6).(18,22) C1GalT1 adds a Gal residue in β1,3 linkage to Tn,…”
BackgroundSelf-citationTherapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease
Sun, J., Shen, X., Li, Y., Guo, Z., Zhu, W., Zuo, L., Zhao, J., Gu, L., Gong, J., & Li, J. (2016) · Nutrients · doi:10.3390/nu8010044 · Cited by 107
“If the glycans become short, the degradation process will be too rapid and not only the outer mucus layer but also the inner can be degraded to allow bacteria to reach the epithelium [18,19].”
BackgroundHarvey, D. J. (2011) · Mass Spectrometry Reviews · doi:10.1002/mas.20333 · Cited by 101
Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice
Chugh, S., Barkeer, S., Rachagani, S., Nimmakayala, R. K., Perumal, N., Pothuraju, R., Atri, P., Mahapatra, S., Thapa, I., Talmon, G. A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.007 · Cited by 103
Self-citationAntonini, M., Lo Conte, M., Sorini, C., & Falcone, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01937 · Cited by 88
Gupta, R., Leon, F., Rauth, S., Batra, S. K., & Ponnusamy, M. P. (2020) · Cells · doi:10.3390/cells9020446 · Cited by 84
“The relevance of B3GNT6 has also been elucidated in a Core-3 synthase KO animal model [59].”
BackgroundThe Membrane-Bound Mucin Muc1 Regulates T Helper 17-Cell Responses and Colitis in Mice
Nishida, A., Lau, C. W., Zhang, M., Andoh, A., Shi, H. N., Mizoguchi, E., & Mizoguchi, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.12.036 · Cited by 92
O-glycan recognition and function in mice and human cancers
Cervoni, G. E., Cheng, J. J., Stackhouse, K. A., Heimburg‐Molinaro, J., & Cummings, R. D. (2020) · Biochemical Journal · doi:10.1042/bcj20180103 · Cited by 89
Self-citationVongsa, R. A., Zimmerman, N. P., & Dwinell, M. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805289200 · Cited by 91
Metadata
- Authors
- An, G., Wei, B., Xia, B., McDaniel, J. M., Ju, T., Cummings, R. D., Braun, J., & Xia, L.
- Affiliations
- Oklahoma Medical Research Foundation (US)
- University of California, Los Angeles (US)
- Emory University (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-05-21
- Volume
- 204
- Issue
- 6
- Pages
- 1417-1429
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118614
- OpenAlex
- W2047595952
- Cited by
- 352
- References
- 65
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 16 · 2023: 17 · 2022: 25 · 2021: 26 · 2020: 20 · 2019: 14 · 2018: 20 · 2017: 9 · 2016: 15 · 2015: 21 · 2014: 28 · 2013: 16 · 2012: 20
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL085607)
- National Cancer Institute (P30CA016042)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK069434, R01DK069434)
- National Center for Research Resources (RR 018758, P20RR018758)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- mucin core proteins, MUC2, intestinal mucus, intestinal permeability, colitis, colorectal adenocarcinoma, ulcerative colitis, colorectal cancer, knockout mice, glycosylation
- MeSH terms
- Animals, Colitis, Colon, Disease Susceptibility, Immunohistochemistry, Mucins, Polysaccharides, Immunoblotting, Colorectal Neoplasms, N-Acetylglucosaminyltransferases, DNA Primers, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Microscopy, Electron, Transmission, Mice, Mucin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.